Therapy Areas: Vaccines
North Korea can receive 4.7 million doses of AstraZeneca's COVID-19 vaccine under COVAX allocation plan
30 November 2021 -

Under its allocation plan, global vaccine-sharing facility COVAX has set aside 4.73 million doses of AstraZeneca Plc's (LON:AZN) COVID-19 vaccine for shipment to North Korea, Reuters news agency reported on Tuesday

South Korea's unification ministry, which oversees engagement with the North Korea, said on Tuesday that it appears detailed distribution arrangement has yet to be made, as COVAX continues to engage with the North Korean government.

The allocation is part of the COVAX plan to distribute 43 million doses of the AstraZeneca and Moderna's (Nasdaq:MRNA) COVID-19 vaccines by the end of December 2021, as the facility aims to ship up to one billion vaccine doses in total this year.

According to the WHO, North Korea and Eritrea are the only countries that have yet to start their vaccination campaign against COVID-19.

Also, North Korea has not officially confirmed any COVID-19 cases, but it has imposed strict anti-virus measures, including border closures and domestic travel curbs.



Related Headlines